Page last updated: 2024-10-29

avapro and Gastroparesis

avapro has been researched along with Gastroparesis in 1 studies

Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.

Gastroparesis: Chronic delayed gastric emptying. Gastroparesis may be caused by motor dysfunction or paralysis of STOMACH muscles or may be associated with other systemic diseases such as DIABETES MELLITUS.

Research Excerpts

ExcerptRelevanceReference
"Leptin may cause delayed gastric emptying in the central and peripheral pathways."1.40Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation. ( He, L; Ren, R; Sun, Y; Wang, F; Zhang, Y; Zhu, Y, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
He, L1
Sun, Y1
Zhu, Y1
Ren, R1
Zhang, Y1
Wang, F1

Other Studies

1 other study available for avapro and Gastroparesis

ArticleYear
Improved gastric emptying in diabetic rats by irbesartan via decreased serum leptin and ameliorated gastric microcirculation.
    Genetics and molecular research : GMR, 2014, Sep-05, Volume: 13, Issue:3

    Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Biphenyl Compounds; Blood Glucose; Diabetes Compli

2014